Holen Sie sich die Stockscreener-App
13.78
1.64%
-0.23
Handel nachbörslich:
13.82
0.04
+0.29%
Finanzdaten der Ars Pharmaceuticals Inc-Aktie (SPRY)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | 0.01 | 0.02 |
Operating Expenses
|
29.00%
13.19
|
10.23 | 17.98 | 20.61 | 18.73 |
| Operating Income/Loss |
29.00%
-13.19
|
-10.23 | -17.98 | -20.60 | -18.71 |
| Income/Loss From Continuing Operations Before Tax |
-10.29
|
- | -14.87 | 0.01 | 0.02 |
| Income/Loss From Continuing Operations After Tax |
43.58%
-10.29
|
-7.168 | -14.87 | -17.37 | -14.96 |
|
Net Income/Loss
|
43.58%
-10.29
|
-7.168 | -14.87 | -17.37 | -14.96 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
31,503%
96.49
|
0.3053 | 95.58 | 94.91 | 94.23 |
| Diluted Average Shares |
31,503%
96.49
|
0.3053 | 95.58 | 94.91 | 94.23 |
| Basic Earnings Per Share |
57.14%
-0.11
|
-0.07 | -0.16 | -0.18 | -0.16 |
| Diluted Earnings Per Share |
57.14%
-0.11
|
-0.07 | -0.16 | -0.18 | -0.16 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):